These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 35801303

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG, Hossain P, Jawaid O, Alvandi B, Foley TR, Singh GD, Waldo SW, Laird JR, Armstrong EJ.
    J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
    Sixt S, Carpio Cancino OG, Treszl A, Beschorner U, Macharzina R, Rastan A, Krankenberg H, Neumann FJ, Zeller T.
    J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated Trial.
    Deloose K, Bosiers M, Peeters P, Verbist J, Maene L, Beelen R, Keirse K, Hendriks J, Lauwers P, Wauters J, Verschueren M.
    J Endovasc Ther; 2020 Dec; 27(6):936-945. PubMed ID: 32873131
    [Abstract] [Full Text] [Related]

  • 28. Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
    Teymen B, Akturk S, Akturk U, Tdjani M.
    Vascular; 2018 Feb; 26(1):54-61. PubMed ID: 28708023
    [Abstract] [Full Text] [Related]

  • 29. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.
    Mwipatayi BP, Perera K, Daneshmand A, Daniel R, Wong J, Thomas SD, Burrows SA.
    Vascular; 2018 Feb; 26(1):3-11. PubMed ID: 28436316
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Orbital Atherectomy Prior to Drug-Coated Balloon Angioplasty in Calcified Infrapopliteal Lesions: A Randomized, Multicenter Pilot Study.
    Zeller T, Giannopoulos S, Brodmann M, Werner M, Andrassy M, Schmidt A, Blessing E, Tepe G, Armstrong EJ.
    J Endovasc Ther; 2022 Dec; 29(6):874-884. PubMed ID: 35086385
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Directional atherectomy with antirestenotic therapy for the treatment of no-stenting zones.
    Sauguet A, Philippart R, Honton B.
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):198-204. PubMed ID: 30650962
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E.
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of the efficacy of combined device strategies for long femoropopliteal artery disease.
    Iwata S, Suzuki R, Hosoi Y, Tanaka Y, Izumi Y, Tan M, Urasawa K.
    Cardiovasc Interv Ther; 2024 Jul; 39(3):273-283. PubMed ID: 38635112
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.